
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
← Back HomeBrowse every article and treatment insight.

Lesions larger than 2–4 cm² show material divergence by ten years: OATS transfers hyaline cartilage that withstands active joint loading, whilst microfracture produces fibrocartilage repair tissue that degrades under sustained stress.

An injectable collagen scaffold gels within focal elbow cartilage defects and recruits the body's own progenitor cells to rebuild cartilage in a single ultrasound-guided outpatient visit.

ChondroFiller injection treats talar dome cartilage defects unresponsive to physiotherapy using a collagen scaffold that recruits the patient's own stem cells to regenerate cartilage in a single 30-45 minute clinic appointment, without surgery or general anaesthesia.

ChondroFiller injection gels within minutes, recruiting the body's progenitor cells to repair worn cartilage as an additive scaffold rather than mechanical replacement; each increment of joint-space narrowing reduces the biological substrate available to respond, making early intervention a preservation-first decision.

ChondroFiller injection—an outpatient collagen scaffold—suits defects across multiple joints and ages; MACI requires two separate knee surgeries on a focal, isolated lesion. Most patients eligible for one are unsuitable for the other, making them separate pathways rather than competing options.

A cartilage grade measures how far into the cartilage layer the damage extends, not pain level, prognosis, or surgical need.

Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)